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to those who discussed nothing. CONCLUSIONS: Most men and providers did not 
discuss disadvantages of PSA testing. Men with higher education, being older and 
having a unique personal provider were more likely to have discussed about PSA 
testing with their providers. Discussions with providers had a significant positive 
impact on PSA testing. Providers should discuss completely about PSA testing with 
men to help them in decision making.
PHS94
Long-term imPact of a PHarmaciSt-Led diabeteS medication 
management Program on gLycemic controL
Tran M.1, Godley P.2, Stock E.M.3, Rascati K.L.4, Tabor P.A.2
1Scott & White Health Plan, Austin, TX, USA, 2Scott & White Health Plan, Temple, TX, USA, 
3Center for Applied Health Research - Central Texas Veterans Health Care System jointly with 
Baylor Scott & White Health, Temple, TX, USA, 4The University of Texas at Austin, College of 
Pharmacy, Austin, TX, USA
OBJECTIVES: Due to its chronic nature and the severity of its complications, diabetes 
has major clinical and financial impacts on patients and health care. Evidence sug-
gests that community-based disease management models have the ability to improve 
outcomes for patients with diabetes. Scott & White Health Plan (SWHP) offers a medi-
cation management program (MMP) in which eligible members with diabetes receive 
monthly educational visits with a pharmacist, anti-diabetic medications, and testing 
supplies at no cost. This study aims to evaluate the clinical impact of the diabetes 
MMP offered by SWHP by comparing long-term glycemic control in diabetic patients 
who are enrolled in the MMP to those not enrolled. METHODS: Diabetic patients aged 
18 to 61 at time of MMP enrollment (index) with continuous enrollment in SWHP one 
year prior and four years post-index were included. Patients in MMP must be enrolled 
for four years, with control subjects receiving standard diabetes care during this time. 
Control subjects were matched 2:1 on age, gender, diabetes type (I or II), insulin use, 
and physical comorbidity. HbA1c data were obtained from medical records. Bivariate 
analyses assessed differences in patient characteristics by group. RESULTS: A total 
of 73 diabetic patients were matched with standard care patients for a combined 
sample of 219, with 56% female and mean age 52 years (SD= 5.7). Although MMP 
patients had greater baseline HbA1c (median: 8.8% MMP vs. 7.4% control; p< 0.01 per 
Wilcoxon rank-sum test), they experienced a greater reduction in HbA1c after 4 years 
(median reduction: 1.0% MMP vs. 0.1% control, p< 0.01). Eighteen (25%) MMP patients 
who were uncontrolled at baseline were at or below goal by the end of the study 
period. CONCLUSIONS: Participation of diabetic patients in the MMP demonstrated 
an improvement in glycemic control, supporting the idea that ambulatory pharma-
cists can be effective in community-based diabetes management.
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OBJECTIVES: Objective of this study is to assess a trend of physician visit among 
individuals who were detected as hepatic dysfunction by the annual health checkup 
(Kenshin) which is implemented in Japan. METHODS: This is a retrospective cohort 
study using Japan Medical Data Center (JMDC) database. Annual health checkup 
data in 2012 and the associated claims data were merged by unique identifiers. 
Individuals (18≤ age≤ 64) with ALT> 30(IU/L) as hepatic dysfunction were identified. 
The proportion of individuals who visited a physician office after the annual health 
checkup for liver related diagnosis up to month 3,6,9 and 12 from the date of the 
annual health checkup was evaluated. The number of visits associated with liver 
related diagnosis and confirmed diagnosis with liver-related disease by gender and 
age was assessed. The cox proportional hazard regression model was used to evalu-
ate variables associated with a physician visit. RESULTS: 353,384 individuals were 
received hepatic function tests at the annual health checkup in 2012. 57,059 indi-
viduals were identified ALT> 30(IU/L) without any liver related diagnosis in preceding 
12 months of the annual health checkup. Among them, the cumulative proportion of 
individuals who visited physician office was 4%(month 3), 11%(month 6), 20%(month 
9), and 30%(month 12). 4,379(8%) of individuals were confirmed with liver related 
diagnosis at month 12. Fatty liver was major diagnosis followed by alcoholic hepatic 
disease, virus hepatitis, hepatic fibrosis or cirrhosis and liver cancer. Individuals 
with higher ALT values, older age, and female are more likely to visit physician’s 
office after the annual health checkup. CONCLUSIONS: One in six individuals was 
newly detected with hepatic dysfunction at the annual checkup. Despite of the 
serious consequence of liver related diseases, small number of individuals with 
hepatic dysfunctions detected by the annual health checkup visited physician office 
for further evaluation of the diagnosis.
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OBJECTIVES: Diagnosis of children with attention-deficit/hyperactivity disorder 
(ADHD) is increasing. Recent studies have shown a tendency for younger children 
in a school cohort being diagnosed with the condition, suggesting the diagnosis 
is associated with immaturity. Given potential sequelae of treatment, there is a 
great need to evaluate potential misdiagnosis. The present study sought to identify 
characteristics and treatment patterns of children with ADHD, compare younger 
to older children within single age cohorts, and find seasonality and trends in dis-
parity of diagnosis and pharmacotherapy, within a non-selective real-world set-
ting. METHODS: Children aged 6-11 who were members of Clalit Health Services 
January 2010. Diagnosis (ICD-9 314.[0,1,2,8,9]) and medication (ATC codes ‘N06BAx’) 
were extracted from the Clalit Health Services database. Calendar months of first 
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OBJECTIVES: To evaluate the quality of life (QoL) of diabetic patients and its associ-
ated factors. METHODS: In January to Febrary 2014 patients with diabetes mellitus 
(DM) were interviewed in cities of Minas Gerais State about sociodemographic, clini-
cal and QoL aspects of. QoL was measured by the EuroQol questionnaire (Eq5D). 
Descriptive analysis, correlation, linear regression multivariate analyzes were per-
formed. RESULTS: We interviewed 2,620 patients. Of these, 69% were women, 84% 
had type 2 DM and 10% type 1. The mean age was 61 years (σ = 16). The descriptive 
system Eq5d scores ranged from -0.1896 and 1.000 (μ = 0.7158; σ = 0.22) and for the 
visual analog scale from 0 to 100 (μ = 67.5; σ = 22). These values are consistent with 
the utility values (-0.235 to 0.869) for the general population of Minas Gerais. The 
mean QoL of diabetic patients was 0.716 (σ = 0.22). Multivariate analysis showed that 
the following aspects significantly decrease QoL of the patients: (I) not being able to 
do usual activities; (II) bedridden for sickness; (III) worse self-rated health status; (IV) 
history of arthritis, osteoarthritis or rheumatism; (V) obesity; (VI) depression; (VII) 
stroke; (VIII) retinopathy; (IX) neuropathy; (X) chronic lung disease; (XI) thrombosis; 
(XII) need for help to take medicines; (XIII) growing old; (XIV) years on medication; 
(XV) living alone; (XVI) have been hospitalized in the last 15 days; (XVII) have spent 
money on supplies for diabetes and (XVIII) not do exercise (p < 0.05). CONCLUSIONS: 
The interviewed diabetic patients had worse QoL than the general population and 
the diabetes complications decreases QoL of these patients, which points out to the 
need for better disease control, monitoring and more educational activities that 
effectively contribute to the self-care.
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OBJECTIVES: Breast cancer is the most common cancer and the second highest cause 
of death due to cancer among women. The US Preventive Services Task Force and 
the American Association of Family Physicians recommend biennial mammography 
screening for women aged 50-74. This study is aimed at determining factors associ-
ated with mammography screening among women in this age group. METHODS: 
Women (50-74 years) who participated in the Behavioral Risk Factor Surveillance 
System in 2013 were included (n= 15,426). Weighted mammogram screening preva-
lence within the past two years was estimated and logistic regression was used to 
assess sociodemographic (age, race, marital status, education, income, healthcare 
coverage, employment), clinical (time since last routine check-up and pap smear, 
health status, history of cancer), and lifestyle (physical activity and smoking status) 
factors associated with mammogram screening. RESULTS: Most participants (77.4%) 
reported having a mammogram within the past 2 years. Factors associated with mam-
mogram screening within the past 2 years included: older age (ORs range: 1.26-1.57), 
higher income (ORs range: 1.23-1.50), having a health plan (OR= 2.63;95%CI= 2.22-
3.12), check-up within past year vs. 2 years or more (OR= 5.02;95%CI= 4.30-5.86), pap 
smear within past year vs. 5 years or more (OR= 9.25;95%CI= 8.01-10.69), history of 
cancer (OR= 1.23;95%CI= 1.08-1.39), being physically active (OR= 1.21;95%CI= 1.08-
1.36), and non-smoking (OR= 1.70;95%CI= 1.50-1.93). Blacks were more likely to screen 
than whites (OR= 1.69;95%CI= 1.40-2.04). Those with less than high school education 
were less likely to screen than those who attended college (OR= 0.81;95%CI= 0.66-
0.999). The retired were more likely to screen than those employed for wages 
(OR= 1.31;95%CI= 1.12-1.52). The unmarried were less likely to screen than the mar-
ried (OR= 0.79;95%CI= 0.70-0.90). CONCLUSIONS: Mammogram screening prevalence 
was below the 81.1% recommended by Healthy People 2020. Our findings identified 
population subgroups that may benefit from focused interventions. Policymakers 
may want to consider ensuring that patients have health insurance, regular check-
ups and pap smears.
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OBJECTIVES: Objectives of this study were to explore a) the effect of socio-demo-
graphic and personal characteristics on extent of discussions between men and 
healthcare providers about prostate specific antigen (PSA) testing and b) effect of 
discussions on PSA testing METHODS: This retrospective cross-sectional study ana-
lyzed data collected from the 2012 wave of the Behavioral Risk Factor Surveillance 
System (BRFSS). A discussion with providers about PSA testing was considered as 
a dependent variable. Baseline category logit model was used to measure effect of 
socio-demographic and personal variables on three levels of discussions (complete, 
partial and none). Logistic regression was used to test association between levels 
of discussion and whether a person had PSA test. RESULTS: Among 133,040 males, 
84996 (63.9%) said their providers discussed advantages of PSA with them, while 
94,818 (71.3%) said providers never discussed disadvantages of PSA testing. For 
46,971(35.3%), neither advantages nor disadvantages were discussed. Highest level 
of education, age, recommendation for having a PSA test by provider and having 
a unique personal provider were positively associated with discussions about PSA 
testing. Odds of not having a PSA test was at least 6.67 times (OR = 7.14, 95% CI = 6.67, 
7.69) more for those who had no discussion compared to those who had discussed 
either advantages or disadvantages and was less by at least 81% (OR = 0.18, 95% CI 
= 0.17, 0.19) for those who discussed both advantages and disadvantages compared 
